§ Funding Round
Series B funding round for Amphista Therapeutics raising $53M in March 2021
Series B funding round for Amphista Therapeutics raising $53M in March 2021
| Investor | Firm Type | Partner |
|---|---|---|
ForbionLEAD | Organization | — |
| Angel | therese liechtenstein | |
| Organization | — | |
Omega Funds | — | — |
| Organization | — | |
| Angel | vincent brichard | |
Advent Life Sciences | — | — |
| Organization | — | |
Eli Lilly and Company | — | — |
| Angel | florian müllershausen |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$61M
Top Valuation
-
Amphista Therapeutics raised $53M in a Series B round.
The round was announced on 03/01/21.
The round was led by Forbion.
